Latest in Gilead’s
Sort by
1 items
-
Gilead’s third-quarter earnings beat by a wide margin, and biotech raises guidance
Gilead Sciences Inc.’s stock rose 2.7% in after-hours trading Wednesday, after the biotech blew past third-quarter earnings estimates and raised its guidance, boosted by demand for its HIV and ...Business - MarketWatch - 5 hours ago